Avandia Timeline of Events

The following is a timeline of events in the discovery of dangerous Avandia side effects:

May 1999 - GlaxoSmithKline’s Avandia is approved for market by the Food and Drug Administration (FDA) and is called one of the most promising new medications for Type 2 diabetes, a prevalent medical issue in the U.S.

December 2005 - New information surfaces regarding worsening macular edema in patients taking Avandia.¹

May 2007 - GlaxoSmithKline and FDA alerted healthcare professionals to new information regarding the potential of serious and potentially life-threatening side effects of the popular diabetes mellitus type 2 treating drug Avandia.²

July 2007 - Despite mounting evidence regarding Avandia heart risks and despite FDA drug safety warnings, 2 FDA advisory panels recommended that the Avandia remain on the market.³

September 2007 - The Journal of the American Medical Association finds after four separate clinical trials, one each year, patients taking Avandia run a 42% greater chance of having a heart attack, confirming earlier studies.⁴

November 2007 – According to Times Newspapers published reports, The Journal of the American Medical Association concludes that Actos, a rival diabetes treatment from Takeda Pharmaceuticals, appeared to reduce patients' risk of heart attacks (no comparison with Avandia was done).⁵

February 2010 - The Senate Finance Committee released a report questioning whether the FDA adequately informed the public of the increased risk of heart attacks or whether they ignored safety concerns coming from not only medical professionals but their own drug safety officials.

 

Find out more about the FDA's watch on Avandia that may eventually lead to this prescription drug's recall.

If you are in need of a defective drug lawyer, contact the Simmons firm today. We can help with the filing of your Avandia lawsuit.